EGFR and non-small cell lung carcinoma: Although ICI therapy has promising efficacy in the treatment of EGFR-mutant NSCLC that progressed with prior EGFR-TKI therapy, little is known about the central nervous system (CNS) activities in the subpopulation with BMs.